#doctisproject search results

👩‍🔬 Meet the people behind #DocTISProject! 🔬 In our first young researchers interview, Yolanda Guillén (@IMIDomics) shares how advanced molecular and computational technologies help better understand patient responses. 🔎 doctis.eu/yolanda-guille… #IMID #IMIDs #EUResearch

🧬 The #DocTISProject held its final Scientific Advisory Board meeting as we move towards completion in June 2026. 🙏 We thank the Board for their continuous guidance and support, helping advance progress in #IMIDs and #AutoimmuneTherapies. 🌐 doctis.eu #IMID

🧬 What is #DocTISProject? 🩺 #IMIDs affect millions worldwide, but not all patients respond in the same way. 🔬 DocTIS combines clinical and molecular data with systems biology to advance more personalised treatments. 🔎 Learn more: doctis.eu #IMIDResearch

🩺 #UlcerativeColitis is a chronic immune-mediated inflammatory disease (#IMID) that impacts patients’ quality of life. 🧬 At #DocTISProject, we advance #IMIDResearch to improve therapeutic strategies and patient outcomes. 🔎 Learn more: doctis.eu/ulcerative-col… #EUResearch

📣 Dr @hoheyn (@cnag_eu) presented research using data generated within #DocTISProject at the “Single cell-omics and the Human Cell Atlas” event, organised by @FundacionAreces and @SpringerNature. 👉 More: doctis.eu/single-cell-om… #SingleCellOmics #HumanCellAtlas #IMIDResearch

🧬 On #RareDiseaseDay, taking place tomorrow, #DocTISProject supports @eurordis and reaffirms its commitment to advancing research to address unmet medical needs and ensure no patient is left behind. 🔎 Learn more: doctis.eu/rare-disease-d… #IMID #IMIDs #AutoimmuneTherapies

💊 Advancing combination therapies for #IMIDs requires robust molecular data and strong clinical–research integration. 📢 Dr @hoheyn (@cnag_eu) presented Work Package 4 at the #DocTISProject webinar, focusing on molecular data generation from IMID Biobank patients. #IMID

The study led by @cnag_eu and published in @NatureMedicine, which uses data from the #DocTISProject and maps cellular inflammation at an unprecedented scale, has been featured on one of Spain’s main national TV channels. More info:👉 doctis.eu/cellular-infla… #SingleCell #IMIDs

🔬 #DocTISProject data featured in @NatureMedicine! 🧬 DocTIS contributed to a @cnag_eu-led study on cellular inflammation, developed by @hoheyn, @jc_nietos, @ljimenezgracia, @DMasper0, @saguilarfer, @fcraighero and collaborators. 🔗 doctis.eu/cellular-infla… #NatureMedicine

💊 Patient selection and characterisation are key to research on combination therapies for #IMIDs. 📢 During a #DocTISProject webinar, Dr Maria López Lasanta from H@vallhebron hospital presented the clinical features of #IMID-Biobank patients within WP3 (Patient Selection).

🎄 As Christmas approaches, the #DocTISProject reflects on a year of collaboration and progress in #IMIDResearch. 🔬 We continue working towards better, more personalised #AutoimmuneTherapies for people living with #IMIDs. 🔗 Learn more: doctis.eu #IMID

🔬 #DocTISProject has been granted a six-month extension by @EU_Commission to complete its clinical trial in #IMIDs, ensuring robust patient follow-up and high-quality final results. 🔗 doctis.eu/doctis-six-mon… #immunemediated #IMID #AutoimmuneTherapies #IMIDResearch

🔬 New interview in our #DocTISProject series. 🎤 We spoke with #PereSantamaria from @idibaps: “By combining drugs intelligently, patients who do not respond to #monotherapies can be helped”. 👉 Discover more: doctis.eu/pere-santamari… #IDIBAPS #Autoimmunity #IMID #IMIDs

💊 The #DocTISProject hosted a webinar earlier this year on discovering combination therapies for Immune-Mediated Inflammatory Diseases #IMIDs. 📢 Dr. Sara Marsal from @vallhebron & @VHIR_ introduced the project, outlining its scope and objectives. #IMID

🔬 The #DocTISProject single-cell atlas will be presented at @ACRheum´s #ACR25 in Chicago, the world’s leading #Rheumatology meeting. 🧬 @VHIR_’s Dr. @ToniJuliaC will showcase groundbreaking scRNA-seq insights. 👉 Learn more: doctis.eu/single-cell-at… #IMID #IMIDs #IMIDResearch

🔬 Groundbreaking #DocTISProject study shared at #Viszeralmedizin 2025! 👩‍🔬 Prof. Britta Siegmund (@Charite) presented findings on how patients with different #IMIDs respond to targeted therapies using single-cell RNA sequencing. 🔗 doctis.eu/doctis-study-v… #IMIDResearch

🔬 Our #DocTISProject interview series continues! 🎤 Today: @RickMyers_PhD, CSO of @hudsonalpha. 📣 “I have high hopes for the combination therapy being successful”. 👉 Learn how #Genomics is advancing personalized #IMID treatment: doctis.eu/richard-myers-… #IMIDs #IMIDResearch

📢#DocTISProject findings will be showcased at #UEGWeek2025, Europe’s leading #Gastroenterology congress by @my_UEG. 🔬 On Oct 6, Prof. Britta Siegmund (@ChariteBerlin) presents the first large-scale scRNA-seq analysis of drug responses in #IMIDs. 👉 doctis.eu/doctis-ueg-week

🔬 #DocTISProject has been granted a six-month extension by @EU_Commission to complete its clinical trial in #IMIDs, ensuring robust patient follow-up and high-quality final results. 🔗 doctis.eu/doctis-six-mon… #immunemediated #IMID #AutoimmuneTherapies #IMIDResearch

🧬 What is #DocTISProject? 🩺 #IMIDs affect millions worldwide, but not all patients respond in the same way. 🔬 DocTIS combines clinical and molecular data with systems biology to advance more personalised treatments. 🔎 Learn more: doctis.eu #IMIDResearch

🔬 Groundbreaking #DocTISProject study shared at #Viszeralmedizin 2025! 👩‍🔬 Prof. Britta Siegmund (@Charite) presented findings on how patients with different #IMIDs respond to targeted therapies using single-cell RNA sequencing. 🔗 doctis.eu/doctis-study-v… #IMIDResearch

🔬 #DocTISProject data featured in @NatureMedicine! 🧬 DocTIS contributed to a @cnag_eu-led study on cellular inflammation, developed by @hoheyn, @jc_nietos, @ljimenezgracia, @DMasper0, @saguilarfer, @fcraighero and collaborators. 🔗 doctis.eu/cellular-infla… #NatureMedicine

🔬 Meet the minds behind the #DocTISProject! 🎤 We spoke with @ErnestChoy1, Prof. & Head of #Rheumatology at @cardiffuni: 📣 “I expect more patients will achieve remission with combination biologic treatment”. 👉 doctis.eu/ernest-choy-pa… #IMID #IMIDs #IMIDResearch #Autoimmune

📢 A #DocTISProject study will be presented at #Viszeralmedizin2025! 🎤 Prof. Britta Siegmund (@ChariteBerlin) will share new findings at leading #Gastroenterology event. 📍 Sept 19 🌆 Leipzig, Germany 🔗 doctis.eu/doctis-congres… #IMID #IMIDs #IMIDResearch #MedicalResearch

📢#DocTISProject findings will be showcased at #UEGWeek2025, Europe’s leading #Gastroenterology congress by @my_UEG. 🔬 On Oct 6, Prof. Britta Siegmund (@ChariteBerlin) presents the first large-scale scRNA-seq analysis of drug responses in #IMIDs. 👉 doctis.eu/doctis-ueg-week

📣 Dr @hoheyn (@cnag_eu) presented research using data generated within #DocTISProject at the “Single cell-omics and the Human Cell Atlas” event, organised by @FundacionAreces and @SpringerNature. 👉 More: doctis.eu/single-cell-om… #SingleCellOmics #HumanCellAtlas #IMIDResearch

🎄 As Christmas approaches, the #DocTISProject reflects on a year of collaboration and progress in #IMIDResearch. 🔬 We continue working towards better, more personalised #AutoimmuneTherapies for people living with #IMIDs. 🔗 Learn more: doctis.eu #IMID

🩺 #UlcerativeColitis is a chronic immune-mediated inflammatory disease (#IMID) that impacts patients’ quality of life. 🧬 At #DocTISProject, we advance #IMIDResearch to improve therapeutic strategies and patient outcomes. 🔎 Learn more: doctis.eu/ulcerative-col… #EUResearch

🧬 On #RareDiseaseDay, taking place tomorrow, #DocTISProject supports @eurordis and reaffirms its commitment to advancing research to address unmet medical needs and ensure no patient is left behind. 🔎 Learn more: doctis.eu/rare-disease-d… #IMID #IMIDs #AutoimmuneTherapies

Today, we participated in the @DoctisEU 5th General Assembly meeting (@VHIR_) 🗣️@hoheyn, our Single Cell Genomics Group Leader, presented the results of WP4, which focuses on molecular data generation and our latest advancements #IMID #IMIDResearch #DocTISProject

🔬 New interview in our #DocTISProject series. 🎤 We spoke with #PereSantamaria from @idibaps: “By combining drugs intelligently, patients who do not respond to #monotherapies can be helped”. 👉 Discover more: doctis.eu/pere-santamari… #IDIBAPS #Autoimmunity #IMID #IMIDs

📣 In our latest PI interview, we speak with Giampiero Girolomoni, Head of the #Dermatology Section at @UniVerona: 🗨️ “I was captivated by the ambitious goals of the #DocTISProject”. 👉 Read more: doctis.eu/giampiero-giro… #IMID #IMIDs #AutoimmuneTherapies #IMIDResearch

🧬 The #DocTISProject held its final Scientific Advisory Board meeting as we move towards completion in June 2026. 🙏 We thank the Board for their continuous guidance and support, helping advance progress in #IMIDs and #AutoimmuneTherapies. 🌐 doctis.eu #IMID

👩‍🔬 Meet the people behind #DocTISProject! 🔬 In our first young researchers interview, Yolanda Guillén (@IMIDomics) shares how advanced molecular and computational technologies help better understand patient responses. 🔎 doctis.eu/yolanda-guille… #IMID #IMIDs #EUResearch

📣 Kicking off our #DocTISProject PI interview series with Britta Siegmund, from @ChariteBerlin: “Our disease-specific analyses have gone beyond the theoretical; they’ve led to real action”. 👉 Read more: doctis.eu/britta-siegmun… #IMID #IMIDs #Rheumatology #Gastroenterology

🔬 Our #DocTISProject interview series continues! 🎤 Today: @RickMyers_PhD, CSO of @hudsonalpha. 📣 “I have high hopes for the combination therapy being successful”. 👉 Learn how #Genomics is advancing personalized #IMID treatment: doctis.eu/richard-myers-… #IMIDs #IMIDResearch

📢 Don’t miss Prof. Britta Siegmund from @ChariteBerlin at #Viszeralmedizin2025! 🎤 She will present latest findings from the #DocTISProject. 📅 Sept 19 🕒 15:05 CEST 📍 Leipzig, Germany (@CongressCenterL) 🔗 doctis.eu/doctis-congres… #Gastroenterology #MedicalResearch

🔬 Our #DocTISProject interview series continues! 🎤 Meet @IMIDomics COO #ManuelLopezFigueroa: “DocTIS can reduce time to effective treatment, minimize side effects & improve long-term disease management”. 👉 Read more: doctis.eu/manuel-lopez-f… #IMID #IMIDs #IMIDResearch